Publications by authors named "James Coons"

Claim this Profile
G
Genetic Determinants of Response to P2Y Inhibitors and Clinical Implications.
Larisa H Cavallari, James C Coons

Heart Fail Clin· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation Optimization Through a Specialized Center for Atrial Fibrillation.
James Coons, Virginia Singla, Evan White, Erica Byers, Eric Dueweke

Am J Med Qual· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pericardial effusions and sotatercept therapy in pulmonary arterial hypertension: a multicentre, real-world experience.
Sandeep Sahay, Nelson Villasmil Hernandez, Yassmin Al Aaraj, Rahul G Argula, Roberto J Bernardo, James C Coons

Eur Respir J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Optimization Clinic: Answering a Call to Action.
James C Coons, Jennifer Kliner, Michael A Mathier, Mary E Keebler

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin.
Mujtaba Mahmud, Maia Klimatcheva, Angela Tsang, Andrew La, Victoria Miklus, James C Coons

Clin Appl Thromb Hemost· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist.
Ali Ataya, James C Coons, Natalie Patzlaff, Meredith Broderick, Scott Seaman

JHLT Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing Theoretical Domains Framework to Determine Barriers to Evidence-Based Recommendations in Non-Valvular Atrial Fibrillation.
Evan White, Sandra L Kane-Gill, Sandeep Jain, Charles Medico, Nicole Ansani, James C Coons

Ann Pharmacother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Platform Designed to Empower Quality Improvement for Patients with Atrial Fibrillation.
Thomas F Deering, Anne Marie Smith, John A Gillespie, Julie Simonson, Julie Gouveia-Pisano, James C Coons

Am J Med Qual· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulant use among Medicare patients newly diagnosed with venous thromboembolism (VTE): Factors associated with treatment status.
James C Coons, Aolin Wang, Dominick Latremouille-Viau, Cristina Russ, Dong Cheng

PLoS One· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal pharmacogenomic learning for student pharmacists.
Kaitlyn LeCompte, James C Coons, Philip Empey, Lucas A Berenbrok

Curr Pharm Teach Learn· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Financial Barriers to Optimal Guideline-Directed Medical Therapy for Patients With Heart Failure.
Ronald J Campbell, Jennifer Kliner, Heather Goetze, James C Coons

JACC Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System.
Elizabeth M Foster, James C Coons, Elena A Puccio, Danine Sullinger, Rachel Ibrahim

Ann Pharmacother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the therapeutic utility of the factor XIa inhibitor asundexian.
Jocelyn Edwards, Jack Corey, James C Coons

Am J Health Syst Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication optimization clinic decreases hospitalizations and mortality for patients with heart failure with reduced ejection fraction.
James C Coons, Jennifer Kliner, Michael A Mathier, Suresh Mulukutla, Floyd Thoma

Am Heart J Plus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Determinants of Response to P2Y Inhibitors and Clinical Implications.
Larisa H Cavallari, James C Coons

Interv Cardiol Clin· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus.
Jacqueline Brewer, Melisa Wilson, James C Coons, Ann Schmit, Mary E Whittenhall

Respir Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards consensus recommendations for pharmacogenetics testing.
James C Coons, Philip E Empey

Am J Health Syst Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE).
James C Coons, Vamshi Ruthwik Anupindi, Riddhi Doshi, Mitch DeKoven, Feng Dai

J Clin Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empowering personalized pharmacogenomics with generative AI solutions.
Mullai Murugan, Bo Yuan, Eric Venner, Christie M Ballantyne, Katherine M Robinson, James C Coons

J Am Med Inform Assoc· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DOAC Dosing Discordance Using Different Estimates of Kidney Function and Outcomes.
Nauka J Bhalodia, Evan M White, Archita Achanta, Jesse Cheng, Connor R Deri, James C Coons

J Clin Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management Considerations for Pulmonary Arterial Hypertension Pharmacotherapy in the Intensive Care Unit.
Elizabeth M Foster, Danine Sullinger, James C Coons

Pharmacy (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives.
James C Coons, Philip E Empey

Pharmgenomics Pers Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y Inhibitor Prescribing After Percutaneous Coronary Intervention.
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, James C Lee, Julio D Duarte, James C Coons

Clin Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a Medication Optimization Clinic on Heart Failure Hospitalizations.
James C Coons, Jennifer Kliner, Michael A Mathier, Suresh Mulukutla, Floyd Thoma

Am J Cardiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping.
James C Coons, James M Stevenson, Ami Patel, A J Conrad Smith, Linda Prebehalla

J Cardiovasc Pharmacol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis